Management shuffle at Novavax; plus Skyhawk, Kyverna, Gemini and more

Greg Covino will step down as CFO and become executive adviser to Novavax Inc. (NASDAQ:NVAX). The vaccine developer hired Troy Morgan as SVP and chief compliance officer and promoted Gale Smith to SVP of discovery and preclinical research and chief scientist. Morgan joins from EMD Serono Inc., where he was chief compliance officer.

Skyhawk Therapeutics Inc. named Elliot Ehrich president and hired Graeme Smith as SVP of nonclinical development. Ehrich joined the company as CMO in October 2020. Smith was VP and global head of preclinical safety assessment, bioanalysis and comparative medicine at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)...